RT Book, Section
A1 Albertson, Timothy E.
A2 Olson, Kent R.
A2 Anderson, Ilene B.
A2 Benowitz, Neal L.
A2 Blanc, Paul D.
A2 Clark, Richard F.
A2 Kearney, Thomas E.
A2 Kim-Katz, Susan Y.
A2 Wu, Alan H. B.
SR Print(0)
ID 1179990744
T1 BARBITURATES
T2 Poisoning & Drug Overdose, 7e
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071839792
LK accessmedicine.mhmedical.com/content.aspx?aid=1179990744
RD 2024/04/25
AB Barbiturates  have  been  used  as  hypnotic  and  sedative  agents,  for  the  induction  of  anesthesia,  and  for  the  treatment  of  epilepsy  and  status  epilepticus.  They  have  been  largely  replaced  by  newer  drugs  and  calls  to  poison  control  centers  have  decreased  significantly.  They  often  are  divided  into  four  major  groups  according  to  their  pharmacologic  activity  and  clinical  use:  ultra–short-acting,  short-acting,  intermediate-acting,  and  long-acting  (Table  II–13);  and  combination  products  containing  barbiturates  include  Fiorinal  (50  mg  butalbital)  and  Donnatal  (16  mg  phenobarbital).  Veterinary  euthanasia  products  often  contain  barbiturates  such  as  pentobarbital.